DingKeYiLiao

http://www.dkinfo.cn/tg/

Weekly News Amount
Total
${lastRankDetail.pages.length}
Financing ${lastRankDetail.financing_pages.length}
Product ${lastRankDetail.product_pages.length}
Negative ${lastRankDetail.sentiment_pages.length}
DingKeYiLiao is a high-tech company specializing in the research and development and production of vascular interventional medical treatment products, and has completed several registration tests and animal experiments of three types of products, among which DingKeYiLiao has the pre-market clinical trial of coronary drug balloon DCB ( Drug Coated Balloon ) Dissove TM with independent PCT intellectual property rights

Signals

Events ${currentEventsPage.count} Events
Events (${currentEventsPage.count}) Date
Nothing Happens :-(
${e.desp} ${e.date}
News ${ rankDetail.pages.length } News Articles ${currentTimeRange.start} ~ ${currentTimeRange.end}
Article (${rankDetail.pages.length}) Tag
${article.en_title} ${article.tag}
Industry Financing Info

Research

Intelligence 0 Research Briefs

Competition

Competitors 5 Competitors
Company Industry Series Amount Announced Date

Adagene

Adagene is committed to developing a new generation of biopharmaceutical companies with therapeutic and diagnostic antibody technology, using its own dynamic precision antibody technology ( DPL ) to develop new drugs leading the industry

Healthcare

series C

50 million USD

27/3/2018

ZhiShanWeiXin

ZhiShanWeiXin is a biotechnology enterprise focusing on gene therapy and integrating gene drug research and development, technical service, technology transformation, large-scale production and sales. The future development of gene therapy drugs in ZhiShanWeiXin will focus on genetic diseases and neurodegenerative diseases

Healthcare

series A

Hundreds of millions CNY

9/2/2021

GemPharmatech

GemPharmatech is a high-tech biotechnological enterprise specializing in the research and development of humanized models and drug screening technologies. It has the leading research and development capability of disease models and the research and development center of genetically engineered mice models

Healthcare

series B

400 million CNY

11/9/2020

KangPoShengWuYiYao

KangPoShengWuYiYao is a biomedical research and development company. Based on a new generation of protein ubiquitination and degradation technologies, KangPoShengWuYiYao focuses on the fields of cancer, autoimmune diseases and inflammation. Its main products are KPG—121 combined with Nzaroamine. Users can treat metastatic castration-resistant prostate cancer

Healthcare

series B

Nearly 100 million CNY

9/8/2019

MabPlex

MabPlex is a one-stop outsourcing service provider for biopharmaceutical research and development and GMP production. The company mainly provides users with a series of biopharmaceutical research and development and production outsourcing services such as monoclonal antibody, recombinant protein, antibody drug coupling, etc. It can also provide the whole process solution of cytotoxin synthesis, linker production and coupling during antibody drug coupling ( ADC ) drug research and development

Healthcare

series B

500 million CNY

8/6/2020